Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zakaria Chakrani
Observed name:
Z. Chakrani
Institution:
Icahn School of Medicine at Mount Sinai
Observed institution:
Icahn School of Medicine at Mount Sinai
ORCID:
0009-0003-2932-6960
Observed ORCID:
0009-0003-2932-6960
OpenAlex ID:
A5016844446
Randomized Controlled Trials Comparing Bone‐Patellar Tendon‐Bone Versus Hamstring Tendon Autografts in Anterior Cruciate Ligament Reconstruction Surgery Are Statistically Fragile: A Systematic Review
2023
·
Kyle W. Lawrence
, Jeffrey O. Okewunmi
, et al.
·
Arthroscopy The Journal of Arthroscopic and Related Surgery
·
19
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy
2024
·
George Mellgard
, Nathaniel Saffran
, et al.
·
American Journal of Clinical Oncology
·
4
PDF
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy
2024
·
Zakaria Chakrani
, George Mellgard
, et al.
·
American Journal of Clinical Oncology
·
4
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)
2024
·
Zakaria Chakrani
, Mann Patel
, et al.
·
Clinical Genitourinary Cancer
·
1
Prolonged Opioid Use and Associated Factors After Open Reduction and Internal Fixation of Tibial Shaft Fractures
2024
·
Zakaria Chakrani
, Carolina Stocchi
, et al.
·
Orthopedics
Preoperative Cervical Epidural Steroid Injections: Utilization and Postoperative Complications in ACDF, PCDF, and Decompression
2024
·
Husni Alasadi
, Joydeep Baidya
, et al.
·
Clinical Spine Surgery A Spine Publication
Survival outcomes and toxicity in older adults with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted (ART) therapies.
2023
·
George Slade Mellgard
, Zakaria Chakrani
, et al.
·
Journal of Clinical Oncology
PDF
Risk factors for treatment (tx) toxicity and discontinuation among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) on androgen receptor targeted therapy (ART).
2023
·
Zakaria Chakrani
, George Slade Mellgard
, et al.
·
Journal of Clinical Oncology
Clinical characteristics and outcomes of trial-ineligible patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving androgen receptor targeted (ART) therapy.
2023
·
George Slade Mellgard
, Stephen Mccroskery
, et al.
·
Journal of Clinical Oncology
The effect of statin use on survival outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted therapies (ART).
2023
·
George Slade Mellgard
, Nathaniel Saffran
, et al.
·
Journal of Clinical Oncology
1274P Performance status (PS) and end-of-life (EOL) care in patients (pts) with metastatic prostate cancer (mPC) treated with androgen receptor targeted (ART) therapy
2022
·
G. Mellgard
, Z. Chakrani
, et al.
·
Annals of Oncology
25. Perioperative complications associated with epidural injections followed by cervical decompression and fusion
2022
·
Husni Alasadi
, Zakaria Chakrani
, et al.
·
The Spine Journal
Show more works
View as search
Works count:
12
Citation count:
28
H-index:
3
I10-index:
1
Year
Topic
Type